4Filed Aug 9, 8:00 PM ET

Phibro (PAHC) Director & 10% Owner Jack Bendheim Receives 12,103 RSUs

$PAHC · PHIBRO ANIMAL HEALTH CORP

Research Summary

AI-generated summary of this SEC filing

Updated

Phibro (PAHC) Director & 10% Owner Jack Bendheim Receives 12,103 RSUs

What Happened
Jack Bendheim, a director, officer and reported 10% owner of Phibro Animal Health Corp (PAHC), was granted 12,103 restricted stock units (RSUs) on 2026-08-06. The award was granted at $0.00 (i.e., no cash paid at grant). Each RSU represents a contingent right to receive one share of Class A common stock upon vesting.

Key Details

  • Transaction type: Award/Grant (code A).
  • Date of grant: 2026-08-06; filing date: 2026-08-10.
  • Amount: 12,103 RSUs granted at $0.00 (immediate cash value at grant = $0).
  • Vesting: RSUs vest in substantially equal installments on each of the first three anniversaries of August 1, 2026 (roughly Aug 1 of 2027, 2028 and 2029), subject to continued employment.
  • RSU mechanics: Each RSU converts to one share of Class A common stock when vested.
  • Holdings after transaction: The filing does not list a total beneficial ownership after the grant. The reported securities are directly held by Bendheim and by BFI Co., LLC. Bendheim exercises voting/dispositive power over BFI and disclaims beneficial ownership of BFI-held securities except for any pecuniary interest.
  • Timeliness: Filing was submitted on 2026-08-10 (no late-filing notation in the summary information provided).

Context
RSU grants are a form of compensation intended to align executives/directors with shareholders; they do not represent an immediate purchase of stock and have value only if/when they vest and the stock has market value. As a 10% owner and controller of BFI Co., LLC, Bendheim’s holdings may include both his direct RSUs and interests held through that entity. This award is informational for investors tracking insider alignment but does not by itself indicate an immediate change in share supply or insider buying/selling.